CR9792A - Composiciones que contienen piperacilina y tazobactam utiles para inyecciones (divisional de exp. 8035) - Google Patents

Composiciones que contienen piperacilina y tazobactam utiles para inyecciones (divisional de exp. 8035)

Info

Publication number
CR9792A
CR9792A CR9792A CR9792A CR9792A CR 9792 A CR9792 A CR 9792A CR 9792 A CR9792 A CR 9792A CR 9792 A CR9792 A CR 9792A CR 9792 A CR9792 A CR 9792A
Authority
CR
Costa Rica
Prior art keywords
piperacilin
divisional
injections
exp
compositions containing
Prior art date
Application number
CR9792A
Other languages
English (en)
Inventor
Marc Cohen Jonathan
Muzafar Shah Syed
Lutyer Ofslager Christian
Bakir Fawzi Mahdi
Original Assignee
Wyeth Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=32326726&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=CR9792(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Wyeth Corp filed Critical Wyeth Corp
Publication of CR9792A publication Critical patent/CR9792A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A61K31/429—Thiazoles condensed with heterocyclic ring systems
    • A61K31/43—Compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula, e.g. penicillins, penems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A61K31/429—Thiazoles condensed with heterocyclic ring systems
    • A61K31/43—Compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula, e.g. penicillins, penems
    • A61K31/431—Compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula, e.g. penicillins, penems containing further heterocyclic rings, e.g. ticarcillin, azlocillin, oxacillin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/496—Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • A61K47/183—Amino acids, e.g. glycine, EDTA or aspartame
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A61P31/06—Antibacterial agents for tuberculosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Abstract

Se ha comprobado que un agente quelante de acido aminocaboxilico, de preferencia EDTA o una sal con el mismo compuesto, resultan utiles para inhibir la formacion de particulas en combinaciones parenterales de piperacilina , tazobactam. Asimismo, la composicion puede contener un buffer, de preferencia un citrato y un aminoglicosidode manera opcional.
CR9792A 2003-04-14 2008-03-04 Composiciones que contienen piperacilina y tazobactam utiles para inyecciones (divisional de exp. 8035) CR9792A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US46280803P 2003-04-14 2003-04-14

Publications (1)

Publication Number Publication Date
CR9792A true CR9792A (es) 2008-09-23

Family

ID=32326726

Family Applications (2)

Application Number Title Priority Date Filing Date
CR8035A CR8035A (es) 2003-04-14 2005-10-07 Composiciones que contienen piperacilina y tazobactam utiles para inyecciones
CR9792A CR9792A (es) 2003-04-14 2008-03-04 Composiciones que contienen piperacilina y tazobactam utiles para inyecciones (divisional de exp. 8035)

Family Applications Before (1)

Application Number Title Priority Date Filing Date
CR8035A CR8035A (es) 2003-04-14 2005-10-07 Composiciones que contienen piperacilina y tazobactam utiles para inyecciones

Country Status (35)

Country Link
US (3) US7498312B2 (es)
EP (1) EP1468697B1 (es)
JP (1) JP4644659B2 (es)
KR (1) KR100824554B1 (es)
CN (1) CN1802179B (es)
AR (1) AR043863A1 (es)
AT (1) ATE381947T1 (es)
AU (1) AU2004229407B2 (es)
BR (1) BRPI0409450B8 (es)
CA (1) CA2464258C (es)
CH (1) CH695185A9 (es)
CL (1) CL2004000782A1 (es)
CO (1) CO5700796A2 (es)
CR (2) CR8035A (es)
CY (1) CY1108064T1 (es)
DE (1) DE602004010862T2 (es)
DK (1) DK1468697T3 (es)
EC (1) ECSP056100A (es)
ES (1) ES2298672T3 (es)
FR (1) FR2853547B1 (es)
GB (1) GB2400557B (es)
HK (1) HK1069775A1 (es)
IL (1) IL171337A (es)
MX (1) MXPA05010996A (es)
MY (1) MY139099A (es)
NO (1) NO20054789L (es)
NZ (1) NZ543005A (es)
PL (1) PL1468697T3 (es)
PT (1) PT1468697E (es)
RU (2) RU2322980C2 (es)
SA (1) SA04250119B1 (es)
SI (1) SI1468697T1 (es)
TW (1) TWI308069B (es)
WO (1) WO2004091666A1 (es)
ZA (1) ZA200508315B (es)

Families Citing this family (39)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP5591434B2 (ja) 2002-12-20 2014-09-17 ゼリス ファーマシューティカルズ インコーポレイテッド 皮内注射方法
PL1468697T3 (pl) * 2003-04-14 2008-05-30 Wyeth Corp Kompozycje zawierające piperacyklinę i tazobaktam przydatne do wstrzykiwań
AU2005295644A1 (en) * 2004-10-14 2006-04-27 Wyeth Compositions containing piperacillin, tazobactam and a aminocarboxilic acid in a sodium lactate diluent
EP1841432B1 (en) * 2004-12-02 2010-08-11 Venus Remedies Limited Compositions for combating beta-lactamase-mediated antibiotic resistance using beta-lactamase inhibitors useful for injection
ES2284318B1 (es) * 2005-04-13 2008-11-01 Labiana Development, S.L. Procedimiento de obtencion de una mezcla en polvo de una sal sodica de piperaciclina y tazobactama, util para su administracion por via inyectable.
ITMI20051630A1 (it) * 2005-09-02 2007-03-03 Acs Dobfar Spa Formulazione farmaceutica sterile iniettabile contenente almeno due principi attivi
CN1927201B (zh) * 2006-08-25 2011-06-01 天津和美生物技术有限公司 含哌拉西林的抗生素复方
CN101129382B (zh) * 2006-08-25 2013-12-25 天津和美生物技术有限公司 含β-内酰胺类抗生素和缓冲组分的抗生素复方
CN102210679B (zh) * 2006-08-25 2013-03-13 天津和美生物技术有限公司 含哌拉西林的抗生素复方
CN101129383B (zh) * 2006-08-25 2014-04-02 天津和美生物技术有限公司 含氨基糖苷类抗生素的抗生素复方
CN102441169A (zh) * 2006-08-25 2012-05-09 天津和美生物技术有限公司 含β-内酰胺类抗生素和离子螯合剂的抗生素复方
CN101129381B (zh) * 2006-08-25 2012-02-01 天津和美生物技术有限公司 含β-内酰胺类抗生素和离子螯合剂的抗生素复方
CN101265263B (zh) * 2008-05-12 2010-06-02 海南百那医药发展有限公司 哌拉西林钠他唑巴坦钠复方注射剂的生产方法
WO2010013640A1 (ja) * 2008-07-28 2010-02-04 Yamaguchi Keizo 感染症治療効果増強剤
JP5852316B2 (ja) * 2010-03-30 2016-02-03 富山化学工業株式会社 ピペラシリン含有懸濁液の製造法
US20120046225A1 (en) 2010-07-19 2012-02-23 The Regents Of The University Of Colorado, A Body Corporate Stable glucagon formulations for the treatment of hypoglycemia
CN107260729B (zh) 2010-11-25 2020-03-31 阿莱克拉治疗有限公司 β-内酰胺化合物及其用途
SG193389A1 (en) 2011-03-10 2013-10-30 Xeris Pharmaceuticals Inc Stable formulations for parenteral injection of peptide drugs
JP6117811B2 (ja) 2011-10-31 2017-04-19 ゼリス ファーマシューティカルズ インコーポレイテッド 糖尿病を処置するための製剤
TR201820073T4 (tr) 2012-03-26 2019-01-21 Santen Pharmaceutical Co Ltd Diquafosol içeren göz damlası.
US9125805B2 (en) 2012-06-27 2015-09-08 Xeris Pharmaceuticals, Inc. Stable formulations for parenteral injection of small molecule drugs
US8476425B1 (en) 2012-09-27 2013-07-02 Cubist Pharmaceuticals, Inc. Tazobactam arginine compositions
KR101816798B1 (ko) * 2012-10-19 2018-01-10 주식회사유한양행 피페라실린 또는 그의 염, 타조박탐 또는 그의 염 및 덱사메타손 포스페이트 또는 그의 염을 포함하는 국소투여용 약학 조성물
US9018162B2 (en) 2013-02-06 2015-04-28 Xeris Pharmaceuticals, Inc. Methods for rapidly treating severe hypoglycemia
US20140274993A1 (en) 2013-03-15 2014-09-18 Cubist Pharmaceuticals, Inc. Ceftolozane-tazobactam pharmaceutical compositions
CN110279698B (zh) 2013-03-15 2022-10-28 默沙东有限责任公司 头孢特咯瓒抗生素组合物
US9872906B2 (en) 2013-03-15 2018-01-23 Merck Sharp & Dohme Corp. Ceftolozane antibiotic compositions
US10376496B2 (en) 2013-09-09 2019-08-13 Merck, Sharp & Dohme Corp. Treating infections with ceftolozane/tazobactam in subjects having impaired renal function
US20150094293A1 (en) 2013-09-27 2015-04-02 Calixa Therapeutics, Inc. Solid forms of ceftolozane
JP6982495B2 (ja) 2014-08-06 2021-12-17 ゼリス ファーマシューティカルズ インコーポレイテッド ペーストの皮内および／または皮下注射のためのシリンジ、キット、および方法
KR20170067709A (ko) * 2014-10-08 2017-06-16 사와이세이야쿠 가부시키가이샤 동결 건조 제제의 제조 방법
US9649364B2 (en) 2015-09-25 2017-05-16 Xeris Pharmaceuticals, Inc. Methods for producing stable therapeutic formulations in aprotic polar solvents
US11590205B2 (en) 2015-09-25 2023-02-28 Xeris Pharmaceuticals, Inc. Methods for producing stable therapeutic glucagon formulations in aprotic polar solvents
CA2983256A1 (en) * 2016-03-31 2017-10-05 Wockhardt Limited Antibacterial compositions
WO2018025248A1 (en) * 2016-08-05 2018-02-08 Jodas Expoim Private Limited Edta injection and process for making the same
CN117085022A (zh) 2017-06-02 2023-11-21 Xeris药物公司 抗沉淀的小分子药物制剂
US11110054B2 (en) * 2018-05-09 2021-09-07 Slayback Pharma Llc Ready-to-use injectable pharmaceutical compositions comprising neostigmine and glycopyrrolate
CN112618486B (zh) * 2020-12-24 2023-07-18 浙江昂利康制药股份有限公司 一种注射用混悬油剂及其制备方法
CN113209030B (zh) * 2021-04-27 2023-04-25 海南通用康力制药有限公司 哌拉西林钠他唑巴坦钠无菌粉针剂的制备方法

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4534977A (en) * 1981-03-26 1985-08-13 American Cyanamid Company Composition of matter comprising a low bulk density lyophilized preparation of Sodium Piperacillin
US4477452A (en) * 1981-03-26 1984-10-16 American Cyanamid Company Composition of matter comprising a lyophilized preparation of a penicillin derivative
US4562073A (en) * 1982-12-24 1985-12-31 Taiho Pharmaceutical Company Limited Penicillin derivatives
US5763480A (en) * 1994-02-14 1998-06-09 The Jewish Hospital Of St. Louis Inhibitors of cell-medicated disorders
US5580856A (en) * 1994-07-15 1996-12-03 Prestrelski; Steven J. Formulation of a reconstituted protein, and method and kit for the production thereof
US6503881B2 (en) * 1996-08-21 2003-01-07 Micrologix Biotech Inc. Compositions and methods for treating infections using cationic peptides alone or in combination with antibiotics
US6207661B1 (en) * 1999-02-22 2001-03-27 Baxter International Inc. Premixed formulation of piperacillin sodium and tazobactam sodium injection
WO2003088914A2 (en) * 2002-04-18 2003-10-30 The University Of Iowa Research Foundation Methods of inhibiting and treating bacterial biofilms by metal chelators
PL1468697T3 (pl) * 2003-04-14 2008-05-30 Wyeth Corp Kompozycje zawierające piperacyklinę i tazobaktam przydatne do wstrzykiwań
US6900184B2 (en) * 2003-04-14 2005-05-31 Wyeth Holdings Corporation Compositions containing pipercillin and tazobactam useful for injection
AU2003230899A1 (en) * 2003-04-14 2004-11-26 Wyeth Holdings Corporation Compositions containing piperacillin and tazobactam useful for injection

Also Published As

Publication number Publication date
CA2464258C (en) 2005-06-07
MY139099A (en) 2009-08-28
ATE381947T1 (de) 2008-01-15
CN1802179B (zh) 2011-09-14
CO5700796A2 (es) 2006-11-30
US7498312B2 (en) 2009-03-03
DE602004010862D1 (de) 2008-02-07
SA04250119B1 (ar) 2008-03-30
PL1468697T3 (pl) 2008-05-30
US20110166091A1 (en) 2011-07-07
FR2853547A1 (fr) 2004-10-15
US20090176720A1 (en) 2009-07-09
KR100824554B1 (ko) 2008-04-24
RU2005135135A (ru) 2006-06-10
DK1468697T3 (da) 2008-04-14
US7915229B2 (en) 2011-03-29
DE602004010862T2 (de) 2009-01-02
EP1468697B1 (en) 2007-12-26
SI1468697T1 (sl) 2008-04-30
TW200503758A (en) 2005-02-01
GB2400557B (en) 2005-06-15
NO20054789D0 (no) 2005-10-18
BRPI0409450B1 (pt) 2016-07-12
BRPI0409450A (pt) 2006-05-02
KR20060014375A (ko) 2006-02-15
AU2004229407B2 (en) 2010-04-22
CR8035A (es) 2006-05-30
AR043863A1 (es) 2005-08-17
WO2004091666A8 (en) 2005-11-10
MXPA05010996A (es) 2005-12-12
PT1468697E (pt) 2008-03-05
US20060234995A1 (en) 2006-10-19
NO20054789L (no) 2005-12-13
ZA200508315B (en) 2008-04-30
JP2006523695A (ja) 2006-10-19
RU2322980C2 (ru) 2008-04-27
TWI308069B (en) 2009-04-01
WO2004091666A1 (en) 2004-10-28
NZ543005A (en) 2009-03-31
FR2853547B1 (fr) 2006-08-04
ES2298672T3 (es) 2008-05-16
CY1108064T1 (el) 2014-02-12
GB0407853D0 (en) 2004-05-12
US8133883B2 (en) 2012-03-13
CH695185A5 (fr) 2006-01-13
RU2007142454A (ru) 2009-05-27
EP1468697A1 (en) 2004-10-20
BRPI0409450B8 (pt) 2021-05-25
GB2400557A (en) 2004-10-20
CA2464258A1 (en) 2004-10-14
HK1069775A1 (en) 2005-06-03
IL171337A (en) 2011-03-31
CN1802179A (zh) 2006-07-12
JP4644659B2 (ja) 2011-03-02
CH695185A9 (fr) 2006-02-28
CL2004000782A1 (es) 2005-03-04
ECSP056100A (es) 2006-03-01
AU2004229407A1 (en) 2004-10-28

Similar Documents

Publication Publication Date Title
CR9792A (es) Composiciones que contienen piperacilina y tazobactam utiles para inyecciones (divisional de exp. 8035)
AR021049A1 (es) Una composicion detergente solida
BRPI0408382A (pt) composição contendo materiais de zinco particulado que têm um tamanho definido de cristalito
AR021370A1 (es) Composiciones farmaceuticas inyectables estabilizadas que contienen agentes anti-neoplasicos taxoides
BRPI0414711A (pt) processo para a desoxidação de superfìcies metálicas, e, composições aquosa, ácida para a desoxidação de superfìcies metálicas
AR007536A1 (es) Una composicion de escamas de aditivo para distribuir un agente de beneficio, un procedimiento para formarla, una composicion de barra detocador moldeada por extrusion que la comprende, y un metodo de aumento de la deposicion del agente de beneficio desde una composicion de barra.
PA8587301A1 (es) Composiciones para remover manchas de superficies dentales y metodos de fabricacion y uso de ellas
MX2007007312A (es) Composiciones multifase estructuradas y suaves para la limpieza personal.
MX9301032A (es) Compuestos farmaceuticos y procedimento para su preparacion
CR9887A (es) Composiciones acidas para limpieza
CO4920220A1 (es) Composiciones que contienen compuestos fluoroeter y metodos para inhibir su degradacion en presencia de un acido de lewis
UA97346C2 (ru) Стабильная эмульсионная композиция
CL2004000959A1 (es) Metodo para elaborar un aceite que comprende en alimentar un pez con una composicion que comprende acido araquidonico y extraer un aceite que comprende al menos 2% en peso de acido araquidonico desde dicho pez, aceite de pescado y su uso.
CL2004000026A1 (es) Uso de una composicion que comprende 0 a alrededor de 29% de cis-clomifeno y de alrededor de 100 a alrededor de 71% de trans-clomifeno para preparar un medicamento util para aumentar los niveles de testosterona en suero en un mamifero masculino.
WO2001091738A3 (en) Naaladase inhibitors for treating amyotrophic lateral sclerosis
EA200401434A1 (ru) Обработка опасного, являющегося отходом, материала
ATE475631T1 (de) Partikel eines geschmolzenen keramikmaterials
BR0214810A (pt) Combinação de um inibidor de il-1/18 com um inibidor de tnf para o tratamento de inflamação
DK1274883T3 (da) Korrosionsinhibitor
TW200640369A (en) Anti-bacterial composition and anti-bacterial material
CR7515A (es) Composicion veterinaria inyectable para animales pequenos
AR044449A1 (es) Composiciones acuosas desinfectantes y/o bactericidas
ES2123830T3 (es) Metodo para limpiar superficies de vinilo mediante composiciones ligeramente acidas para limpiar superficies duras que contienen tensioactivos detergentes de oxido de amina.
AR020703A1 (es) Barra de limpieza de superficies duras.
HUP0104606A2 (hu) Egy profent tartalmazó gyógyszerészeti keverék

Legal Events

Date Code Title Description
FA Abandonment or withdrawal (granting procedure)